Page last updated: 2024-09-03

ezogabine and ica 27243

ezogabine has been researched along with ica 27243 in 9 studies

Compound Research Comparison

Studies
(ezogabine)
Trials
(ezogabine)
Recent Studies (post-2010)
(ezogabine)
Studies
(ica 27243)
Trials
(ica 27243)
Recent Studies (post-2010) (ica 27243)
383262411708

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalby-Brown, W; Munro, G1
Bakshi, T; Bhamidipati, R; Brady, P; Cato, M; Chapman, M; Chaudhary, KW; Donovan, B; Dougherty, RW; Downie, D; Fu, T; Higgins, GA; Holenz, J; Kuppusamy, BM; Lin, H; Lluel, P; Madhyastha, N; Matsuoka, Y; Mohd, Z; Morrow, D; Pasikanti, K; Rajagopal, S; Rouget, C; Samanta, SK; Seefeld, MA; Zhen, W1
Nielsen, AN; Redrobe, JP1
Gerlach, AC; McCormack, K; Padilla, K; Wickenden, AD1
Blom, SM; Jensen, HS; Schmitt, N1
Hansen, HH; Kristensen, LV; Sandager-Nielsen, K2
Hansen, HH; Jensen, MM; Lange, SC; Mikkelsen, JD; Thomsen, MS1
Hayashi, H; Iwata, M; Matsumoto, T; Tsuchimori, N1

Reviews

1 review(s) available for ezogabine and ica 27243

ArticleYear
Kv7 (KCNQ) channel modulators and neuropathic pain.
    Journal of medicinal chemistry, 2007, May-31, Volume: 50, Issue:11

    Topics: Analgesics; Animals; Humans; Ion Channel Gating; KCNQ Potassium Channels; Pain; Peripheral Nervous System Diseases; Signal Transduction

2007

Other Studies

8 other study(ies) available for ezogabine and ica 27243

ArticleYear
Novel K
    Bioorganic & medicinal chemistry letters, 2018, 12-15, Volume: 28, Issue:23-24

    Topics: Animals; Anticonvulsants; Epilepsy; Humans; KCNQ Potassium Channels; Mice; Muscle Contraction; Muscle, Smooth; Protein Isoforms; Seizures; Urinary Bladder

2018
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.
    Behavioural brain research, 2009, Mar-17, Volume: 198, Issue:2

    Topics: Amphetamine; Animals; Anticonvulsants; Antimanic Agents; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Indoles; Injections, Intraperitoneal; KCNQ Potassium Channels; Lamotrigine; Lithium Compounds; Male; Mice; Mice, Inbred C57BL; Motor Activity; Phenylenediamines; Pyridines; Triazines

2009
The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
    Neuroscience letters, 2009, Nov-13, Volume: 465, Issue:2

    Topics: Amino Acid Sequence; Animals; Anticonvulsants; Benzamides; Binding Sites; Carbamates; CHO Cells; Cricetinae; Cricetulus; Humans; KCNQ Potassium Channels; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Membrane Potentials; Membrane Transport Modulators; Molecular Sequence Data; Mutation; Phenylenediamines; Pyridines; Sequence Alignment; Tryptophan

2009
Differential effects of ICA-27243 on cloned K(V)7 channels.
    Pharmacology, 2010, Volume: 86, Issue:3

    Topics: Animals; Benzamides; Binding Sites; Carbamates; Cells, Cultured; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Female; KCNQ Potassium Channels; KCNQ2 Potassium Channel; Membrane Potentials; Oocytes; Phenylenediamines; Pyridines; Rubidium Radioisotopes; Xenopus laevis

2010
Kv7 (KCNQ) channel openers induce hypothermia in the mouse.
    Neuroscience letters, 2011, Jan-20, Volume: 488, Issue:2

    Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Body Temperature Regulation; Carbamates; Female; Hypothermia; Indoles; KCNQ Potassium Channels; Mice; Phenylenediamines; Protein Isoforms; Pyridines

2011
The pharmacological effect of positive KCNQ (Kv7) modulators on dopamine release from striatal slices.
    Basic & clinical pharmacology & toxicology, 2011, Volume: 109, Issue:5

    Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Carbamates; Dopamine; Dopamine Antagonists; In Vitro Techniques; Indoles; Inhibitory Concentration 50; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mesencephalon; Neostriatum; Neurons; Nonlinear Dynamics; Phenylenediamines; Potassium Channel Blockers; Potassium Chloride; Pyridines; Rats; Rats, Wistar; Regression Analysis

2011
K(v) 7 (KCNQ) channel openers normalize central 2-deoxyglucose uptake in a mouse model of mania and increase prefrontal cortical and hippocampal serine-9 phosphorylation levels of GSK3β.
    Journal of neurochemistry, 2012, Volume: 121, Issue:3

    Topics: Animals; Antimanic Agents; Autoradiography; Benzamides; Bipolar Disorder; Carbamates; Central Nervous System Stimulants; Chlordiazepoxide; Deoxyglucose; Dextroamphetamine; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypnotics and Sedatives; KCNQ Potassium Channels; Male; Mice; Mice, Inbred C57BL; Phenylenediamines; Phosphorylation; Prefrontal Cortex; Pyridines; Serine

2012
Activation of peripheral KCNQ channels attenuates inflammatory pain.
    Molecular pain, 2014, Feb-21, Volume: 10

    Topics: Animals; Anthracenes; Anticonvulsants; Benzamides; Carbamates; Disease Models, Animal; Electric Stimulation; Exploratory Behavior; Formaldehyde; Freund's Adjuvant; Functional Laterality; Hyperalgesia; Inflammation; KCNQ Potassium Channels; Motor Skills Disorders; Pain; Pain Measurement; Pain Threshold; Phenylenediamines; Potassium Channel Blockers; Pyridines; Rats

2014